Global Preventable Vaccines Market 2015-2019 with GlaxoSmithKline, Merck, Novartis, Pfizer & Sanofi Dominating

News provided by

Feb 25, 2015, 12:04 ET

DUBLIN, Feb. 25, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/8bv33m/global) has announced the addition of the "Global Preventable Vaccines Market 2015-2019" report to their offering.

The analysts forecast the Global Preventable Vaccines market to grow at a CAGR of 10.16% over the period 2014-2019

Vaccines can be defined as a product that stimulates a person's immune system to produce immunity to a specific disease, thereby protecting the person from that disease. According to the CDC, vaccines are usually administered through needle injections, but can also be administered orally or sprayed into the nose. Vaccines can be used for both adults and infants and adolescents. Pediatric vaccines are used for the immunization of children to give protection against various infectious diseases such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases.

One major trend emerging in the market is the strategic alliances of the vendors in the market, resulting in consolidation. M&A are usually intended to increase the market penetration of the acquirer or to enhance the product portfolio of the parent company. Large pharmaceutical companies are focused on consolidating their position in the Global Preventable Vaccines market.

According to the report, the primary driving factor is the inclusion of pediatric vaccines in the national immunization schedule of many countries. This helps increase the consumption of vaccines in the market, thereby boosting growth.

Further, the report states that the inadequate vaccine coverage in the world is a major challenge to the growth of the market. Lack of awareness and negligence among individuals, besides the subsidies offered by governments for a particular age group, are the most prominent factors that decrease these coverage rates.

Key Vendors